FL Graham

473 total citations
10 papers, 402 citations indexed

About

FL Graham is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, FL Graham has authored 10 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in FL Graham's work include Virus-based gene therapy research (8 papers), Cancer Research and Treatments (2 papers) and CAR-T cell therapy research (2 papers). FL Graham is often cited by papers focused on Virus-based gene therapy research (8 papers), Cancer Research and Treatments (2 papers) and CAR-T cell therapy research (2 papers). FL Graham collaborates with scholars based in Canada, Australia and Italy. FL Graham's co-authors include Jack Gauldie, Mary Hitt, Jonathan L. Bramson, Silvia Bacchetti, Yuichi Ohkawara, Manel Jordana, Zhou Xing, Denis P. Snider, WJ Muller and Jean‐Michel Sallenave and has published in prestigious journals such as Leukemia, Gene Therapy and International Journal of Oncology.

In The Last Decade

FL Graham

10 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
FL Graham Canada 9 229 191 135 124 48 10 402
Lisa Cardoza United States 7 314 1.4× 274 1.4× 139 1.0× 130 1.0× 53 1.1× 9 487
Anagha P. Phadke United States 10 207 0.9× 223 1.2× 124 0.9× 152 1.2× 118 2.5× 14 527
S M Rookes United Kingdom 10 118 0.5× 187 1.0× 117 0.9× 205 1.7× 184 3.8× 10 483
S Yei United States 8 316 1.4× 330 1.7× 84 0.6× 80 0.6× 116 2.4× 9 592
Naomi Tsurutani Japan 12 100 0.4× 238 1.2× 148 1.1× 135 1.1× 59 1.2× 17 560
J. Bagley United States 11 85 0.4× 193 1.0× 161 1.2× 55 0.4× 46 1.0× 15 465
T. Kinoshita Japan 13 98 0.4× 199 1.0× 65 0.5× 181 1.5× 56 1.2× 37 604
K E Dolter United States 10 90 0.4× 204 1.1× 88 0.7× 60 0.5× 93 1.9× 11 368
R Bonifer Germany 8 131 0.6× 96 0.5× 193 1.4× 80 0.6× 88 1.8× 10 386
Semyon Rubinchik United States 11 105 0.5× 230 1.2× 47 0.3× 76 0.6× 35 0.7× 14 351

Countries citing papers authored by FL Graham

Since Specialization
Citations

This map shows the geographic impact of FL Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FL Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FL Graham more than expected).

Fields of papers citing papers by FL Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FL Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FL Graham. The network helps show where FL Graham may publish in the future.

Co-authorship network of co-authors of FL Graham

This figure shows the co-authorship network connecting the top 25 collaborators of FL Graham. A scholar is included among the top collaborators of FL Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FL Graham. FL Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ng, P, et al.. (2004). Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors. Gene Therapy. 11(6). 504–511. 33 indexed citations
2.
Trudel, Suzanne, Sulaiman Nanji, Yong Wan, et al.. (2001). Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study. Leukemia. 15(5). 846–854. 27 indexed citations
3.
Sallenave, Jean‐Michel, Zhimin Xing, A. John Simpson, FL Graham, & Jack Gauldie. (1998). Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters. Gene Therapy. 5(3). 352–360. 41 indexed citations
4.
Snider, Denis P., et al.. (1997). Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFα. Gene Therapy. 4(11). 1181–1188. 57 indexed citations
5.
Tomanin, Rosella, Luigi Picci, Laura Ventura, et al.. (1997). In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated gene transfer. Gene Therapy. 4(5). 442–448. 17 indexed citations
6.
Bramson, Jonathan L., Mary Hitt, Jack Gauldie, & FL Graham. (1997). Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Therapy. 4(10). 1069–1076. 97 indexed citations
7.
Xing, Zhou, Yuichi Ohkawara, Manel Jordana, FL Graham, & Jack Gauldie. (1997). Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Therapy. 4(2). 140–149. 66 indexed citations
8.
Gauldie, Jack, et al.. (1995). AN ADENOVIRAL VECTOR EXPRESSING INTERLEUKIN-4 MODULATES TUMORIGENICITY AND INDUCES REGRESSION IN A MURINE BREAST-CANCER MODEL. International Journal of Oncology. 7(6). 1253–60. 25 indexed citations
9.
Jelı́nek, Tomáš, et al.. (1994). THE ADENOVIRUS E1A-ASSOCIATED P300 PROTEIN IS DIFFERENTIALLY PHOSPHORYLATED IN AD12 E1A-COMPARED TO AD5 E1A-TRANSFORMED RAT-CELLS. International Journal of Oncology. 5(6). 1197–205. 3 indexed citations
10.
Bacchetti, Silvia & FL Graham. (1993). INHIBITION OF CELL-PROLIFERATION BY AN ADENOVIRUS VECTOR EXPRESSING THE HUMAN WILD TYPE-P53 PROTEIN. International Journal of Oncology. 3(5). 781–8. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Cardoza Breakdown of academic impact, for papers by Anagha P. Phadke Breakdown of academic impact, for papers by S M Rookes Breakdown of academic impact, for papers by S Yei Breakdown of academic impact, for papers by Naomi Tsurutani Breakdown of academic impact, for papers by J. Bagley Breakdown of academic impact, for papers by T. Kinoshita Breakdown of academic impact, for papers by K E Dolter Breakdown of academic impact, for papers by R Bonifer Breakdown of academic impact, for papers by Semyon Rubinchik
Rankless by CCL
2026